Transforming oral drug development with Formulite®
Disruptive Pharma is a Swedish clinical-stage pharmaceutical development company focused on improving oral drug performance through our proprietary Formulite®platform. Built on a clinically validated amorphous formulation technology, Formulite addresses one of the most persistent challenges in drug development: poor oral bioavailability.
The company combines a scalable, IP-protected technology platform with a selective pipeline of added-value drug product candidates and technology-driven partnering. Operating with a capital-efficient model, Disruptive Pharma targets attractive partnering and licensing opportunities across multiple therapeutic areas.
Disruptive Pharma’s value creation is centred around Formulite, designed to improve oral drug performance and manufacturability.
